Harry J Gould is an accomplished inventor based in New Orleans, LA (US). He has made significant contributions to the field of cancer treatment, holding 2 patents that focus on innovative methods for targeting malignant cancer cells.

Latest Patents

Gould's latest patents include groundbreaking methods for the targeted osmotic lysis of malignant cancer cells using pulsed magnetic field gradients. These methods aim to target cancer cells that over-express voltage-gated sodium channels (VGSCs). The process involves initially inhibiting the sodium, potassium-adenosine triphosphatase (Na, K-ATPase) and subsequently stimulating the VGSCs with pulsed magnetic field gradients. This stimulation causes sodium and water to enter the cancer cells, leading to osmotic lysis. Another patent focuses on a targeted osmotic lysis (TOL) of tumor cells that over-express VGSCs. This method combines a drug that blocks Na, K-ATPase with an activation of VGSCs, resulting in a significant influx of sodium and water into cancer cells, causing them to swell and lyse. Importantly, non-cancerous cells do not over-express VGSCs, thus minimizing damage to healthy tissues.

Career Highlights

Gould is affiliated with Louisiana State University and Agricultural & Mechanical College, where he continues to advance research in cancer therapies. His work has the potential to impact various types of cancer, including highly invasive breast cancer, prostate cancer, small cell lung cancer, non-small cell lung carcinoma, lymphoma, mesothelioma, neuroblastoma, and cervical cancer.

Collaborations

Gould collaborates with Dennis J Paul, contributing to the development of innovative cancer treatment methods.

Conclusion

Harry J Gould's innovative approaches to cancer treatment demonstrate the potential for targeted therapies to improve patient outcomes. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.